To remove potential confounders from mutations in other splicing factors, we looked for differentially spliced events between samples with U2AF1 S34F/Y mutation and samples harboring no mutation in any splicing factor gene that has been previously reported to be significantly altered in cancer (Tables S1–S2 in Document S1). This evidence concerns the gene SLU7 and cancer.